EUCTR2007-005222-69-IT进行中（未招募）不适用
Randomized phase II trial evaluating the activity and the tolerability of fixed dose of oxycodone and increasing dose of pregabalin versus increasing dose of oxycodone and fixed dose of pregabalin - ND
Associazione Progetto Oncologia UMAN.A0 个研究点开始时间: 2008年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-written informed consent -instrumental and clinical diagnosis of every malignant neoplasm -presence of pain with a neuropatic component in the opinion of the physician -presence of pain >=4 (NRS) -PS ECOG <3
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-serum creatinine >2mg/ml or creatinine clearance <40 ml/min -mild or severe hepatic insufficiency -iatrogenic neuropathy caused by chemotherapeutic agents -previous allergic reactions to oxycodone and pregabalin -pregnancy or breastfeeding
研究者
相似试验
进行中（未招募）
不适用
A randomized phase II study to assess the activity and tolerability of two regimens of metronomic oral chemotherapy methotrexate plus cyclophosphamide and cyclophosphamide plus capecitabine combined with bevacizumab in advanced breast cancer - NDEUCTR2005-005046-39-ITISTITUTO EUROPEO DI ONCOLOGIA92
招募中
2 期
A Randomized & Observational phase II trial comparing the activity of TrabectedIn vs gemCitabine in patients with metastatic or locally advanced LEiomyosarcoma pretreated with conventional chemotherapy2024-513820-40-00Italian Sarcoma Group100
已完成
2 期
Randomized phase II trial to evaluate the effectiveness of azacitidine for low risk MDS.lower risk myelodysplastic syndromeJPRN-UMIN000010855ational Research Group on Idiopathic Bone Marrow Failure Syndromes100
已完成
2 期
A randomized phase 2 trial which investigate the most effective administration method of antithrombin (AT) products in patients with disseminated intravascular coagulation (DIC) associated with sepsis during treatment for advanced pancreatic and biliary cancer.advanced hepatobiliary and pancreatic cancer patientsJPRN-UMIN000015105Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Medical Oncology40
进行中（未招募）
1 期
Randomized phase II trial evaluating the efficacy of FOLFOX alone, FOLFOX plus bevacizumab and FOLFOX plus panitumumab as perioperative treatment in patients with resectable liver metastases from wild type KRAS colorectal cancerResectable liver metastases from wild type KRAS colorectal cancer.MedDRA version: 14.1Level: PTClassification code 10052358Term: Colorectal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10024700Term: Liver metastasesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-019238-29-GBEuropean Organisation for Research and Treatment of Cancer44